Brian Abrahams Score: 38
Analyst at
RBC Capital
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+8.9%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
55%
41 W / 34 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
70%
46 W / 20 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
20%
13 W / 53 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
6%
4 W / 62 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
46%
19 W / 22 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
51%
30 W / 29 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
69%
11 W / 5 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 08, 2026 |
Apogee Therapeutics Inc.
APGE
|
BUY |
$97.00
Est. +12%
|
$86.92 | $133.85 |
Target Met
|
$132.91
+52.9%
|
| Jun 01, 2026 |
Gilead Sciences, Inc.
GILD
|
SELL |
$122.00
Est. +9%
|
$134.43 | $121.39 (Low) |
Bullseye Hit (±1%)
|
$131.27
+2.4%
|
| May 27, 2026 |
Biogen Inc
BIIB
|
BUY |
$227.00
Est. +18%
|
$193.08 | $219.00 |
Pending
|
$216.12
+11.9%
|
| May 05, 2026 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$543.00
Est. +26%
|
$429.85 | $529.08 |
Precision Hit (±3%)
|
$528.04
+22.8%
|
| Apr 30, 2026 |
Biogen Inc
BIIB
|
BUY |
$222.00
Est. +16%
|
$190.78 | $219.00 |
Precision Hit (±3%)
|
$216.12
+13.3%
|
| Mar 02, 2026 |
Regeneron Pharmaceuticals, Inc.
REGN
|
SELL |
$765.00
Est. +2%
|
$784.06 | $591.52 (Low) |
Target Met
|
$654.27
+16.6%
|
| Feb 26, 2026 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$108.00
Est. +18%
|
$91.87 | $130.05 |
Target Met
|
$113.51
+23.6%
|
| Feb 24, 2026 |
Galapagos NV - ADR
GLPG
|
SELL |
$33.00
Est. +4%
|
$34.36 | $26.42 (Low) |
Target Met
|
$27.98
+18.6%
|
| Feb 20, 2026 |
PTC Therapeutics Inc
PTCT
|
BUY |
$82.00
Est. +21%
|
$67.95 | $87.03 |
Target Met
|
$83.31
+22.6%
|
| Jan 27, 2026 |
Regeneron Pharmaceuticals, Inc.
REGN
|
SELL |
$745.00
Est. +3%
|
$769.05 | $591.52 (Low) |
Target Met
|
$654.27
+14.9%
|
| Jan 22, 2026 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$546.00
Est. +18%
|
$461.14 | $529.08 |
Pending
|
$528.04
+14.5%
|
| Nov 21, 2025 |
Contineum Therapeutics Inc. - Ordinary Shares - Class A
CTNM
|
BUY |
$22.00
Est. +80%
|
$12.22 | $16.93 |
Pending
|
$15.10
+23.6%
|
| Nov 04, 2025 |
Karyopharm Therapeutics Inc
KPTI
|
BUY |
$19.00
Est. +239%
|
$5.60 | $10.99 |
Pending
|
$9.60
+71.4%
|
| Oct 22, 2025 |
Galapagos NV - ADR
GLPG
|
SELL |
$28.00
Est. +11%
|
$31.43 | $26.42 (Low) |
Target Met
|
$27.98
+11.0%
|
| Sep 24, 2025 |
Cidara Therapeutics Inc
CDTX
|
BUY |
$137.00
Est. +55%
|
$88.58 | $221.42 |
Target Met
|
$221.38
+149.9%
|
| Sep 16, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$70.00
Est. +45%
|
$48.27 | $130.05 |
Target Met
|
$113.51
+135.2%
|
| Sep 15, 2025 |
Atyr Pharma Inc
ATYR
|
BUY |
$1.50
Est. +47%
|
$1.02 | $1.37 |
Pending
|
$0.59
-41.9%
|
| Jun 25, 2025 |
Biogen Inc
BIIB
|
BUY |
$213.00
Est. +67%
|
$127.31 | $206.66 |
Precision Hit (±3%)
|
$216.12
+69.8%
|
| Jun 17, 2025 |
Vertex Pharmaceuticals, Inc.
VRTX
|
SELL |
$420.00
Est. +5%
|
$441.99 | $362.50 (Low) |
Target Met
|
$528.04
-19.5%
|
| Jan 10, 2025 |
IGM Biosciences Inc
IGMS
|
SELL |
$1.50
Est. +28%
|
$2.09 | $0.92 (Low) |
Target Met
|
$1.27
+39.2%
|
| Jan 07, 2025 |
PTC Therapeutics Inc
PTCT
|
BUY |
$58.00
Est. +30%
|
$44.61 | $87.23 |
Target Met
|
$83.31
+86.8%
|
| Jan 07, 2025 |
Sage Therapeutics Inc
SAGE
|
SELL |
$5.00
Est. +16%
|
$5.98 | $5.45 (Low) |
Miss
|
$8.68
-45.2%
|
| Jan 07, 2025 |
Gilead Sciences, Inc.
GILD
|
SELL |
$83.00
Est. +8%
|
$90.63 | $88.58 (Low) |
Miss
|
$131.27
-44.8%
|
| Jan 02, 2025 |
Neumora Therapeutics Inc.
NMRA
|
BUY |
$4.00
Est. +103%
|
$1.97 | $3.25 |
Miss
|
$1.67
-15.2%
|
| Dec 19, 2024 |
Vertex Pharmaceuticals, Inc.
VRTX
|
SELL |
$400.00
Est. +15%
|
$469.22 | $362.50 (Low) |
Target Met
|
$528.04
-12.5%
|
| Nov 29, 2024 |
Applied Therapeutics Inc
APLT
|
SELL |
$4.00
Est. +58%
|
$9.42 | $0.22 (Low) |
Target Met
|
$0.10
+98.9%
|
| Nov 20, 2024 |
Sage Therapeutics Inc
SAGE
|
SELL |
$4.00
Est. +19%
|
$4.91 | $4.62 (Low) |
Miss
|
$8.68
-76.8%
|
| Nov 05, 2024 |
Vertex Pharmaceuticals, Inc.
VRTX
|
SELL |
$451.00
Est. +10%
|
$499.88 | $362.50 (Low) |
Target Met
|
$528.04
-5.6%
|
| Oct 09, 2024 |
Vertex Pharmaceuticals, Inc.
VRTX
|
SELL |
$437.00
Est. +5%
|
$458.94 | $362.50 (Low) |
Target Met
|
$528.04
-15.1%
|
| Oct 01, 2024 |
IGM Biosciences Inc
IGMS
|
BUY |
$17.00
Est. +3%
|
$16.54 | $20.35 |
Target Met
|
$1.27
-92.3%
|
| Sep 09, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,282.00
Est. +13%
|
$1,139.41 | $1,170.58 |
Miss
|
$654.27
-42.6%
|
| Aug 29, 2024 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$136.00
Est. +10%
|
$123.76 | $154.61 |
Target Met
|
$174.26
+40.8%
|
| Aug 09, 2024 |
Gilead Sciences, Inc.
GILD
|
SELL |
$72.00
Est. +5%
|
$75.59 | $72.43 (Low) |
Bullseye Hit (±1%)
|
$131.27
-73.7%
|
| Aug 08, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$181.00
Est. +29%
|
$140.06 | $144.22 |
Miss
|
$19.28
-86.2%
|
| Aug 08, 2024 |
Intra-Cellular Therapies Inc
ITCI
|
BUY |
$106.00
Est. +44%
|
$73.63 | $131.98 |
Target Met
|
$131.87
+79.1%
|
| Aug 06, 2024 |
89bio Inc
ETNB
|
BUY |
$12.00
Est. +49%
|
$8.03 | $11.84 |
Precision Hit (±3%)
|
$14.84
+84.8%
|
| Aug 02, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,240.00
Est. +13%
|
$1,093.14 | $1,211.20 |
Precision Hit (±3%)
|
$654.27
-40.1%
|
| Jul 31, 2024 |
Incyte Corp.
INCY
|
BUY |
$66.00
Est. +0%
|
$65.70 | $83.94 |
Target Met
|
$116.86
+77.9%
|
| Jul 29, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$182.00
Est. +23%
|
$147.88 | $150.48 |
Miss
|
$19.28
-87.0%
|
| Jul 26, 2024 |
Biogen Inc
BIIB
|
BUY |
$282.00
Est. +32%
|
$214.16 | $219.44 |
Miss
|
$216.12
+0.9%
|
| Jun 28, 2024 |
CVS Health Corp
CVS
|
BUY |
$74.00
Est. +26%
|
$58.58 | $72.51 |
Precision Hit (±3%)
|
$104.72
+78.8%
|
| Jun 18, 2024 |
Xenon Pharmaceuticals Inc
XENE
|
BUY |
$55.00
Est. +52%
|
$36.25 | $46.00 |
Miss
|
$60.96
+68.2%
|
| Jun 18, 2024 |
Intra-Cellular Therapies Inc
ITCI
|
BUY |
$103.00
Est. +36%
|
$75.48 | $131.98 |
Target Met
|
$131.87
+74.7%
|
| Jun 17, 2024 |
Neumora Therapeutics Inc.
NMRA
|
BUY |
$29.00
Est. +199%
|
$9.71 | $17.19 |
Miss
|
$1.67
-82.8%
|
| Jun 14, 2024 |
Gilead Sciences, Inc.
GILD
|
BUY |
$74.00
Est. +14%
|
$64.68 | $119.69 |
Target Met
|
$131.27
+103.0%
|
| Jun 13, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,299.00
Est. +27%
|
$1,022.03 | $1,211.20 |
Miss
|
$654.27
-36.0%
|
| Jun 12, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,229.00
Est. +22%
|
$1,010.54 | $1,211.20 |
Precision Hit (±3%)
|
$654.27
-35.3%
|
| Jun 11, 2024 |
Vertex Pharmaceuticals, Inc.
VRTX
|
SELL |
$421.00
Est. +13%
|
$483.28 | $386.66 (Low) |
Target Met
|
$528.04
-9.3%
|
| Jun 11, 2024 |
Corbus Pharmaceuticals Holdings Inc
CRBP
|
BUY |
$82.00
Est. +87%
|
$43.87 | $61.90 |
Miss
|
$9.25
-78.9%
|
| Jun 10, 2024 |
Karyopharm Therapeutics Inc
KPTI
|
BUY |
$3.00
Est. +216%
|
$0.95 | $135.00 |
Target Met
|
$9.60
+910.5%
|
| Jun 06, 2024 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$141.00
Est. +5%
|
$133.69 | $157.98 |
Target Met
|
$174.26
+30.3%
|
| Jun 05, 2024 |
Mind Medicine Inc
MNMD
|
BUY |
$22.00
Est. +167%
|
$8.25 | $10.44 |
Miss
|
$20.69
+150.8%
|
| Jun 05, 2024 |
Definium Therapeutics, Inc.
DFTX
|
BUY |
$22.00
Est. +167%
|
$8.25 | - | - |
$44.19
+435.6%
|
| Jun 04, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,200.00
Est. +20%
|
$998.64 | $1,211.20 |
Bullseye Hit (±1%)
|
$654.27
-34.5%
|
| May 28, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$142.00
Est. +15%
|
$123.46 | $155.95 |
Target Met
|
$19.28
-84.4%
|
| May 20, 2024 |
Corbus Pharmaceuticals Holdings Inc
CRBP
|
BUY |
$77.00
Est. +71%
|
$45.00 | $61.90 |
Miss
|
$9.25
-79.4%
|
| May 20, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$157.00
Est. +20%
|
$130.70 | $155.95 |
Bullseye Hit (±1%)
|
$19.28
-85.2%
|
| May 09, 2024 |
IGM Biosciences Inc
IGMS
|
BUY |
$20.00
Est. +114%
|
$9.34 | $22.50 |
Target Met
|
$1.27
-86.4%
|
| May 07, 2024 |
Intra-Cellular Therapies Inc
ITCI
|
BUY |
$96.00
Est. +35%
|
$71.21 | $131.98 |
Target Met
|
$131.87
+85.2%
|
| May 07, 2024 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$424.00
Est. +5%
|
$402.50 | $519.88 |
Target Met
|
$528.04
+31.2%
|
| May 07, 2024 |
Pliant Therapeutics Inc
PLRX
|
BUY |
$45.00
Est. +226%
|
$13.79 | $16.07 |
Miss
|
$1.17
-91.5%
|
| May 03, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,185.00
Est. +26%
|
$937.61 | $1,211.20 |
Precision Hit (±3%)
|
$654.27
-30.2%
|
| May 02, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$141.00
Est. +8%
|
$130.90 | $155.95 |
Target Met
|
$19.28
-85.3%
|
| Apr 30, 2024 |
Contineum Therapeutics Inc. - Ordinary Shares - Class A
CTNM
|
BUY |
$30.00
Est. +88%
|
$16.00 | $21.92 |
Miss
|
$15.10
-5.6%
|
| Apr 25, 2024 |
Biogen Inc
BIIB
|
BUY |
$317.00
Est. +57%
|
$201.99 | $237.98 |
Miss
|
$216.12
+7.0%
|
| Apr 17, 2024 |
Sage Therapeutics Inc
SAGE
|
BUY |
$26.00
Est. +115%
|
$12.12 | $13.46 |
Miss
|
$8.68
-28.4%
|
| Apr 11, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,189.00
Est. +29%
|
$921.34 | $1,211.20 |
Precision Hit (±3%)
|
$654.27
-29.0%
|
| Mar 13, 2024 |
Neumora Therapeutics Inc.
NMRA
|
BUY |
$31.00
Est. +109%
|
$14.81 | $17.19 |
Miss
|
$1.67
-88.7%
|
| Feb 14, 2024 |
Gilead Sciences, Inc.
GILD
|
BUY |
$76.00
Est. +3%
|
$73.53 | $106.69 |
Target Met
|
$131.27
+78.5%
|
| Jan 12, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,076.00
Est. +15%
|
$933.20 | $1,211.20 |
Target Met
|
$654.27
-29.9%
|
| Oct 10, 2023 |
Neumora Therapeutics Inc.
NMRA
|
BUY |
$24.00
Est. +120%
|
$10.91 | $15.99 |
Miss
|
$1.67
-84.7%
|
| Sep 27, 2023 |
Gilead Sciences, Inc.
GILD
|
BUY |
$84.00
Est. +11%
|
$75.90 | $84.88 |
Precision Hit (±3%)
|
$131.27
+73.0%
|
| Jun 23, 2022 |
PTC Therapeutics Inc
PTCT
|
BUY |
$46.00
Est. +20%
|
$38.29 | - | - |
$83.31
+117.6%
|
| Apr 05, 2022 |
Biogen Inc
BIIB
|
BUY |
$244.00
Est. +18%
|
$207.61 | - | - |
$216.12
+4.1%
|
| Mar 10, 2022 |
Karyopharm Therapeutics Inc
KPTI
|
BUY |
$8.00
Est. +23%
|
$6.49 | $129.45 |
Target Met
|
$9.60
+47.9%
|
| Feb 24, 2022 |
Sage Therapeutics Inc
SAGE
|
BUY |
$37.00
Est. +7%
|
$34.71 | - | - |
$8.68
-75.0%
|
Apogee Therapeutics Inc.
APGE
Jun 08, 2026
Signal & Target
BUY
$97.00
Start Price
$86.92
Best Price (1Y)
$133.85
Current Price
$132.91
Return
+52.9%
Gilead Sciences, Inc.
GILD
Jun 01, 2026
Signal & Target
SELL
$122.00
Start Price
$134.43
Best Price (1Y)
$121.39
Current Price
$131.27
Return
+2.4%
Biogen Inc
BIIB
May 27, 2026
Signal & Target
BUY
$227.00
Start Price
$193.08
Best Price (1Y)
$219.00
Current Price
$216.12
Return
+11.9%
Vertex Pharmaceuticals, Inc.
VRTX
May 05, 2026
Signal & Target
BUY
$543.00
Start Price
$429.85
Best Price (1Y)
$529.08
Current Price
$528.04
Return
+22.8%
Biogen Inc
BIIB
Apr 30, 2026
Signal & Target
BUY
$222.00
Start Price
$190.78
Best Price (1Y)
$219.00
Current Price
$216.12
Return
+13.3%
Regeneron Pharmaceuticals, Inc.
REGN
Mar 02, 2026
Signal & Target
SELL
$765.00
Start Price
$784.06
Best Price (1Y)
$591.52
Current Price
$654.27
Return
+16.6%
Kymera Therapeutics Inc
KYMR
Feb 26, 2026
Signal & Target
BUY
$108.00
Start Price
$91.87
Best Price (1Y)
$130.05
Current Price
$113.51
Return
+23.6%
Galapagos NV - ADR
GLPG
Feb 24, 2026
Signal & Target
SELL
$33.00
Start Price
$34.36
Best Price (1Y)
$26.42
Current Price
$27.98
Return
+18.6%
PTC Therapeutics Inc
PTCT
Feb 20, 2026
Signal & Target
BUY
$82.00
Start Price
$67.95
Best Price (1Y)
$87.03
Current Price
$83.31
Return
+22.6%
Regeneron Pharmaceuticals, Inc.
REGN
Jan 27, 2026
Signal & Target
SELL
$745.00
Start Price
$769.05
Best Price (1Y)
$591.52
Current Price
$654.27
Return
+14.9%
Vertex Pharmaceuticals, Inc.
VRTX
Jan 22, 2026
Signal & Target
BUY
$546.00
Start Price
$461.14
Best Price (1Y)
$529.08
Current Price
$528.04
Return
+14.5%
Signal & Target
BUY
$22.00
Start Price
$12.22
Best Price (1Y)
$16.93
Current Price
$15.10
Return
+23.6%
Karyopharm Therapeutics Inc
KPTI
Nov 04, 2025
Signal & Target
BUY
$19.00
Start Price
$5.60
Best Price (1Y)
$10.99
Current Price
$9.60
Return
+71.4%
Galapagos NV - ADR
GLPG
Oct 22, 2025
Signal & Target
SELL
$28.00
Start Price
$31.43
Best Price (1Y)
$26.42
Current Price
$27.98
Return
+11.0%
Cidara Therapeutics Inc
CDTX
Sep 24, 2025
Signal & Target
BUY
$137.00
Start Price
$88.58
Best Price (1Y)
$221.42
Current Price
$221.38
Return
+149.9%
Kymera Therapeutics Inc
KYMR
Sep 16, 2025
Signal & Target
BUY
$70.00
Start Price
$48.27
Best Price (1Y)
$130.05
Current Price
$113.51
Return
+135.2%
Atyr Pharma Inc
ATYR
Sep 15, 2025
Signal & Target
BUY
$1.50
Start Price
$1.02
Best Price (1Y)
$1.37
Current Price
$0.59
Return
-41.9%
Biogen Inc
BIIB
Jun 25, 2025
Signal & Target
BUY
$213.00
Start Price
$127.31
Best Price (1Y)
$206.66
Current Price
$216.12
Return
+69.8%
Vertex Pharmaceuticals, Inc.
VRTX
Jun 17, 2025
Signal & Target
SELL
$420.00
Start Price
$441.99
Best Price (1Y)
$362.50
Current Price
$528.04
Return
-19.5%
IGM Biosciences Inc
IGMS
Jan 10, 2025
Signal & Target
SELL
$1.50
Start Price
$2.09
Best Price (1Y)
$0.92
Current Price
$1.27
Return
+39.2%
PTC Therapeutics Inc
PTCT
Jan 07, 2025
Signal & Target
BUY
$58.00
Start Price
$44.61
Best Price (1Y)
$87.23
Current Price
$83.31
Return
+86.8%
Sage Therapeutics Inc
SAGE
Jan 07, 2025
Signal & Target
SELL
$5.00
Start Price
$5.98
Best Price (1Y)
$5.45
Current Price
$8.68
Return
-45.2%
Gilead Sciences, Inc.
GILD
Jan 07, 2025
Signal & Target
SELL
$83.00
Start Price
$90.63
Best Price (1Y)
$88.58
Current Price
$131.27
Return
-44.8%
Neumora Therapeutics Inc.
NMRA
Jan 02, 2025
Signal & Target
BUY
$4.00
Start Price
$1.97
Best Price (1Y)
$3.25
Current Price
$1.67
Return
-15.2%
Vertex Pharmaceuticals, Inc.
VRTX
Dec 19, 2024
Signal & Target
SELL
$400.00
Start Price
$469.22
Best Price (1Y)
$362.50
Current Price
$528.04
Return
-12.5%
Applied Therapeutics Inc
APLT
Nov 29, 2024
Signal & Target
SELL
$4.00
Start Price
$9.42
Best Price (1Y)
$0.22
Current Price
$0.10
Return
+98.9%
Sage Therapeutics Inc
SAGE
Nov 20, 2024
Signal & Target
SELL
$4.00
Start Price
$4.91
Best Price (1Y)
$4.62
Current Price
$8.68
Return
-76.8%
Vertex Pharmaceuticals, Inc.
VRTX
Nov 05, 2024
Signal & Target
SELL
$451.00
Start Price
$499.88
Best Price (1Y)
$362.50
Current Price
$528.04
Return
-5.6%
Vertex Pharmaceuticals, Inc.
VRTX
Oct 09, 2024
Signal & Target
SELL
$437.00
Start Price
$458.94
Best Price (1Y)
$362.50
Current Price
$528.04
Return
-15.1%
IGM Biosciences Inc
IGMS
Oct 01, 2024
Signal & Target
BUY
$17.00
Start Price
$16.54
Best Price (1Y)
$20.35
Current Price
$1.27
Return
-92.3%
Regeneron Pharmaceuticals, Inc.
REGN
Sep 09, 2024
Signal & Target
BUY
$1,282.00
Start Price
$1,139.41
Best Price (1Y)
$1,170.58
Current Price
$654.27
Return
-42.6%
Neurocrine Biosciences, Inc.
NBIX
Aug 29, 2024
Signal & Target
BUY
$136.00
Start Price
$123.76
Best Price (1Y)
$154.61
Current Price
$174.26
Return
+40.8%
Gilead Sciences, Inc.
GILD
Aug 09, 2024
Signal & Target
SELL
$72.00
Start Price
$75.59
Best Price (1Y)
$72.43
Current Price
$131.27
Return
-73.7%
Sarepta Therapeutics Inc
SRPT
Aug 08, 2024
Signal & Target
BUY
$181.00
Start Price
$140.06
Best Price (1Y)
$144.22
Current Price
$19.28
Return
-86.2%
Intra-Cellular Therapies Inc
ITCI
Aug 08, 2024
Signal & Target
BUY
$106.00
Start Price
$73.63
Best Price (1Y)
$131.98
Current Price
$131.87
Return
+79.1%
89bio Inc
ETNB
Aug 06, 2024
Signal & Target
BUY
$12.00
Start Price
$8.03
Best Price (1Y)
$11.84
Current Price
$14.84
Return
+84.8%
Regeneron Pharmaceuticals, Inc.
REGN
Aug 02, 2024
Signal & Target
BUY
$1,240.00
Start Price
$1,093.14
Best Price (1Y)
$1,211.20
Current Price
$654.27
Return
-40.1%
Incyte Corp.
INCY
Jul 31, 2024
Signal & Target
BUY
$66.00
Start Price
$65.70
Best Price (1Y)
$83.94
Current Price
$116.86
Return
+77.9%
Sarepta Therapeutics Inc
SRPT
Jul 29, 2024
Signal & Target
BUY
$182.00
Start Price
$147.88
Best Price (1Y)
$150.48
Current Price
$19.28
Return
-87.0%
Biogen Inc
BIIB
Jul 26, 2024
Signal & Target
BUY
$282.00
Start Price
$214.16
Best Price (1Y)
$219.44
Current Price
$216.12
Return
+0.9%
CVS Health Corp
CVS
Jun 28, 2024
Signal & Target
BUY
$74.00
Start Price
$58.58
Best Price (1Y)
$72.51
Current Price
$104.72
Return
+78.8%
Xenon Pharmaceuticals Inc
XENE
Jun 18, 2024
Signal & Target
BUY
$55.00
Start Price
$36.25
Best Price (1Y)
$46.00
Current Price
$60.96
Return
+68.2%
Intra-Cellular Therapies Inc
ITCI
Jun 18, 2024
Signal & Target
BUY
$103.00
Start Price
$75.48
Best Price (1Y)
$131.98
Current Price
$131.87
Return
+74.7%
Neumora Therapeutics Inc.
NMRA
Jun 17, 2024
Signal & Target
BUY
$29.00
Start Price
$9.71
Best Price (1Y)
$17.19
Current Price
$1.67
Return
-82.8%
Gilead Sciences, Inc.
GILD
Jun 14, 2024
Signal & Target
BUY
$74.00
Start Price
$64.68
Best Price (1Y)
$119.69
Current Price
$131.27
Return
+103.0%
Regeneron Pharmaceuticals, Inc.
REGN
Jun 13, 2024
Signal & Target
BUY
$1,299.00
Start Price
$1,022.03
Best Price (1Y)
$1,211.20
Current Price
$654.27
Return
-36.0%
Regeneron Pharmaceuticals, Inc.
REGN
Jun 12, 2024
Signal & Target
BUY
$1,229.00
Start Price
$1,010.54
Best Price (1Y)
$1,211.20
Current Price
$654.27
Return
-35.3%
Vertex Pharmaceuticals, Inc.
VRTX
Jun 11, 2024
Signal & Target
SELL
$421.00
Start Price
$483.28
Best Price (1Y)
$386.66
Current Price
$528.04
Return
-9.3%
Corbus Pharmaceuticals Holdings Inc
CRBP
Jun 11, 2024
Signal & Target
BUY
$82.00
Start Price
$43.87
Best Price (1Y)
$61.90
Current Price
$9.25
Return
-78.9%
Karyopharm Therapeutics Inc
KPTI
Jun 10, 2024
Signal & Target
BUY
$3.00
Start Price
$0.95
Best Price (1Y)
$135.00
Current Price
$9.60
Return
+910.5%
Neurocrine Biosciences, Inc.
NBIX
Jun 06, 2024
Signal & Target
BUY
$141.00
Start Price
$133.69
Best Price (1Y)
$157.98
Current Price
$174.26
Return
+30.3%
Mind Medicine Inc
MNMD
Jun 05, 2024
Signal & Target
BUY
$22.00
Start Price
$8.25
Best Price (1Y)
$10.44
Current Price
$20.69
Return
+150.8%
Definium Therapeutics, Inc.
DFTX
Jun 05, 2024
Signal & Target
BUY
$22.00
Start Price
$8.25
Best Price (1Y)
-
Current Price
$44.19
Return
+435.6%
Regeneron Pharmaceuticals, Inc.
REGN
Jun 04, 2024
Signal & Target
BUY
$1,200.00
Start Price
$998.64
Best Price (1Y)
$1,211.20
Current Price
$654.27
Return
-34.5%
Sarepta Therapeutics Inc
SRPT
May 28, 2024
Signal & Target
BUY
$142.00
Start Price
$123.46
Best Price (1Y)
$155.95
Current Price
$19.28
Return
-84.4%
Corbus Pharmaceuticals Holdings Inc
CRBP
May 20, 2024
Signal & Target
BUY
$77.00
Start Price
$45.00
Best Price (1Y)
$61.90
Current Price
$9.25
Return
-79.4%
Sarepta Therapeutics Inc
SRPT
May 20, 2024
Signal & Target
BUY
$157.00
Start Price
$130.70
Best Price (1Y)
$155.95
Current Price
$19.28
Return
-85.2%
IGM Biosciences Inc
IGMS
May 09, 2024
Signal & Target
BUY
$20.00
Start Price
$9.34
Best Price (1Y)
$22.50
Current Price
$1.27
Return
-86.4%
Intra-Cellular Therapies Inc
ITCI
May 07, 2024
Signal & Target
BUY
$96.00
Start Price
$71.21
Best Price (1Y)
$131.98
Current Price
$131.87
Return
+85.2%
Vertex Pharmaceuticals, Inc.
VRTX
May 07, 2024
Signal & Target
BUY
$424.00
Start Price
$402.50
Best Price (1Y)
$519.88
Current Price
$528.04
Return
+31.2%
Pliant Therapeutics Inc
PLRX
May 07, 2024
Signal & Target
BUY
$45.00
Start Price
$13.79
Best Price (1Y)
$16.07
Current Price
$1.17
Return
-91.5%
Regeneron Pharmaceuticals, Inc.
REGN
May 03, 2024
Signal & Target
BUY
$1,185.00
Start Price
$937.61
Best Price (1Y)
$1,211.20
Current Price
$654.27
Return
-30.2%
Sarepta Therapeutics Inc
SRPT
May 02, 2024
Signal & Target
BUY
$141.00
Start Price
$130.90
Best Price (1Y)
$155.95
Current Price
$19.28
Return
-85.3%
Signal & Target
BUY
$30.00
Start Price
$16.00
Best Price (1Y)
$21.92
Current Price
$15.10
Return
-5.6%
Biogen Inc
BIIB
Apr 25, 2024
Signal & Target
BUY
$317.00
Start Price
$201.99
Best Price (1Y)
$237.98
Current Price
$216.12
Return
+7.0%
Sage Therapeutics Inc
SAGE
Apr 17, 2024
Signal & Target
BUY
$26.00
Start Price
$12.12
Best Price (1Y)
$13.46
Current Price
$8.68
Return
-28.4%
Regeneron Pharmaceuticals, Inc.
REGN
Apr 11, 2024
Signal & Target
BUY
$1,189.00
Start Price
$921.34
Best Price (1Y)
$1,211.20
Current Price
$654.27
Return
-29.0%
Neumora Therapeutics Inc.
NMRA
Mar 13, 2024
Signal & Target
BUY
$31.00
Start Price
$14.81
Best Price (1Y)
$17.19
Current Price
$1.67
Return
-88.7%
Gilead Sciences, Inc.
GILD
Feb 14, 2024
Signal & Target
BUY
$76.00
Start Price
$73.53
Best Price (1Y)
$106.69
Current Price
$131.27
Return
+78.5%
Regeneron Pharmaceuticals, Inc.
REGN
Jan 12, 2024
Signal & Target
BUY
$1,076.00
Start Price
$933.20
Best Price (1Y)
$1,211.20
Current Price
$654.27
Return
-29.9%
Neumora Therapeutics Inc.
NMRA
Oct 10, 2023
Signal & Target
BUY
$24.00
Start Price
$10.91
Best Price (1Y)
$15.99
Current Price
$1.67
Return
-84.7%
Gilead Sciences, Inc.
GILD
Sep 27, 2023
Signal & Target
BUY
$84.00
Start Price
$75.90
Best Price (1Y)
$84.88
Current Price
$131.27
Return
+73.0%
PTC Therapeutics Inc
PTCT
Jun 23, 2022
Signal & Target
BUY
$46.00
Start Price
$38.29
Best Price (1Y)
-
Current Price
$83.31
Return
+117.6%
Biogen Inc
BIIB
Apr 05, 2022
Signal & Target
BUY
$244.00
Start Price
$207.61
Best Price (1Y)
-
Current Price
$216.12
Return
+4.1%
Karyopharm Therapeutics Inc
KPTI
Mar 10, 2022
Signal & Target
BUY
$8.00
Start Price
$6.49
Best Price (1Y)
$129.45
Current Price
$9.60
Return
+47.9%
Sage Therapeutics Inc
SAGE
Feb 24, 2022
Signal & Target
BUY
$37.00
Start Price
$34.71
Best Price (1Y)
-
Current Price
$8.68
Return
-75.0%